Breaking News Instant updates and real-time market news.

TEVA

Teva

$20.77

0.07 (0.34%)

10:44
01/22/18
01/22
10:44
01/22/18
10:44

Teva failed study removes potential upside driver, says Leerink

Leerink analyst Ami Fadia says the failed Phase III registration study evaluating subcutaneously administered reslizumab removes a potential upside driver for Teva Pharmaceutical and puts downside pressure on the stock. The analyst, however, had been skeptical of the subcutaneously administered reslizumab and believes the key branded pipeline contributors remain Austedo and fremanezumab. Fadia has an Underperform rating on Teva shares with a $15 price target.

TEVA Teva
$20.77

0.07 (0.34%)

01/18/18
LEER
01/18/18
NO CHANGE
LEER
Hospitals' entrant could add to generic industry headwinds, says Leerink
After the New York Times reported that a number of the U.S.'s largest hospital systems plan to create a non-profit generic drug company to fight high prices and drug shortages, Leerink analyst Ami Fadia said she doesn't expect this to have an immediate significant impact on pricing, but does view the news as a continuation of the pricing headwinds seen over the past few years. While unclear what development stage the new generics company is at, the formation of such a company would add one more occupant in an already crowded space, added Fadia. Companies in the generic drug space include Teva (TEVA), Mylan (MYL), Novartis (NVS), Endo (ENDP) and Impax (IPXL).
01/18/18
BTIG
01/18/18
DOWNGRADE
BTIG
Neutral
Teva downgraded to Neutral from Buy at BTIG
01/18/18
01/18/18
DOWNGRADE

Neutral
Follow-up: Teva downgraded to Neutral on valuation at BTIG
As previously reported, BTIG downgraded Teva to Neutral from Buy. Analyst Timothy Chiang believes a recovery story is in the making but will take an extended period of time and shares appear fairly valued. Chiang revised Teva's 2018 earnings estimate to $2.75 from $3.13 based on lower revenues, operating costs, and operating income.
01/22/18
WELS
01/22/18
NO CHANGE
WELS
Underperform
Teva can't afford more pipeline setbacks, says Wells Fargo
After Teva (TEVA) reported that its Phase 3 registration study evaluating subcutaneously administered reslizumab in a pre-filled syringe did not meet its primary endpoint, Wells Fargo analyst David Maris said he believes this puts Teva at a disadvantage versus peers AstraZeneca (AZN) and GlaxoSmithKline (GSK) at a time when Teva cannot afford more pipeline setbacks. Subcutaneous reslizumab was not a major focus, but the news is still "another disappointment," said Maris, who keeps an Underperform rating on Teva shares.

TODAY'S FREE FLY STORIES

GE

General Electric

$7.84

-0.2 (-2.49%)

09:04
11/20/18
11/20
09:04
11/20/18
09:04
Hot Stocks
Dragos, GE launch collaboration to strengthen industrial control systems »

Dragos announced its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FIVN

Five9

$38.41

-4.52 (-10.53%)

09:04
11/20/18
11/20
09:04
11/20/18
09:04
Hot Stocks
Five9 selected bu gaming manufacturer to meet compliance contact center »

Five9 announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 27

    Nov

  • 28

    Nov

  • 05

    Dec

  • 11

    Dec

LC

LendingClub

$3.42

-0.13 (-3.66%)

09:03
11/20/18
11/20
09:03
11/20/18
09:03
Hot Stocks
LendingClub issued over $1B in CLub certificates sin launch »

LendingClub has issued…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LOW

Lowe's

$91.34

-1.95 (-2.09%)

, TGT

Target

$77.13

-1.9 (-2.40%)

09:03
11/20/18
11/20
09:03
11/20/18
09:03
Hot Stocks
Fly Intel: Pre-market Movers »

HIGHER: Office Depot…

LOW

Lowe's

$91.34

-1.95 (-2.09%)

TGT

Target

$77.13

-1.9 (-2.40%)

LB

L Brands

$34.53

-0.75 (-2.13%)

MU

Micron

$36.82

-2.63 (-6.67%)

BBY

Best Buy

$62.19

-4.22 (-6.35%)

ODP

Office Depot

$2.94

-0.165 (-5.32%)

PSTG

Pure Storage

$17.56

-1.56 (-8.16%)

CPB

Campbell Soup

$38.47

-0.17 (-0.44%)

ADI

Analog Devices

$85.55

-3.94 (-4.40%)

URBN

Urban Outfitters

$35.61

-1.45 (-3.91%)

KSS

Kohl's

$70.75

-1.73 (-2.39%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 20

    Nov

  • 20

    Nov

  • 20

    Nov

  • 20

    Nov

  • 20

    Nov

  • 20

    Nov

  • 26

    Nov

  • 04

    Dec

  • 05

    Dec

  • 18

    Dec

  • 03

    Mar

AMZN

Amazon.com

$1,511.67

-81.92 (-5.14%)

09:02
11/20/18
11/20
09:02
11/20/18
09:02
Hot Stocks
Amazon Web Services, Pac-12 Conference extend strategic relationship »

Amazon Web Services…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 04

    Dec

MDT

Medtronic

$90.40

-3.28 (-3.50%)

09:02
11/20/18
11/20
09:02
11/20/18
09:02
Hot Stocks
Medtronic says 'more excited than ever' on product pipeline »

Says expects underlying…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 03

    Dec

CRNT

Ceragon Networks

$4.30

0.07 (1.65%)

09:02
11/20/18
11/20
09:02
11/20/18
09:02
Hot Stocks
Zurich Technology Solutions announces agreement with Ceragon Networks »

Zurich Technology…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

  • 04

    Dec

  • 05

    Dec

CRM

Salesforce

$121.00

-11.59 (-8.74%)

09:00
11/20/18
11/20
09:00
11/20/18
09:00
Recommendations
Salesforce analyst commentary  »

Salesforce partner checks…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 27

    Nov

  • 27

    Nov

  • 28

    Nov

  • 29

    Nov

  • 06

    Dec

  • 11

    Dec

  • 03

    Mar

08:57
11/20/18
11/20
08:57
11/20/18
08:57
General news
Redbook Store Sales data reported »

Week of 11/17 Redbook…

CBRL

Cracker Barrel

$174.86

5.18 (3.05%)

08:56
11/20/18
11/20
08:56
11/20/18
08:56
Downgrade
Cracker Barrel rating change  »

Cracker Barrel downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

EQM

EQT Midstream Partners

$47.77

-0.68 (-1.40%)

08:55
11/20/18
11/20
08:55
11/20/18
08:55
Upgrade
EQT Midstream Partners rating change  »

EQT Midstream upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GE

General Electric

$7.84

-0.2 (-2.49%)

, BAC

Bank of America

$27.76

(0.00%)

08:55
11/20/18
11/20
08:55
11/20/18
08:55
Options
Notable open interest changes for November 20th »

Monday's total…

GE

General Electric

$7.84

-0.2 (-2.49%)

BAC

Bank of America

$27.76

(0.00%)

AAPL

Apple

$185.80

-7.62 (-3.94%)

NVDA

Nvidia

$144.66

-19.72 (-12.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 04

    Dec

  • 10

    Dec

  • 12

    Feb

ETRN

Equitrans Midstream

$20.53

-0.34 (-1.63%)

08:55
11/20/18
11/20
08:55
11/20/18
08:55
Initiation
Equitrans Midstream initiated  »

Equitrans Midstream…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZOES

Zoe's Kitchen

$12.75

0.01 (0.08%)

08:55
11/20/18
11/20
08:55
11/20/18
08:55
Conference/Events
Zoe's Kitchen to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

BKI

Black Knight

$45.54

-4.23 (-8.50%)

, DNB

Dun & Bradstreet

$142.62

0.35 (0.25%)

08:53
11/20/18
11/20
08:53
11/20/18
08:53
Recommendations
Black Knight, Dun & Bradstreet analyst commentary  »

Black Knight investment…

BKI

Black Knight

$45.54

-4.23 (-8.50%)

DNB

Dun & Bradstreet

$142.62

0.35 (0.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

MITK

Mitek Systems

$9.42

-0.425 (-4.32%)

08:52
11/20/18
11/20
08:52
11/20/18
08:52
Hot Stocks
Elliott expresses concern over Mitek's refusal to engage with ASG Technologies »

Elliott Management…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INTU

Intuit

$198.50

-12.85 (-6.08%)

08:51
11/20/18
11/20
08:51
11/20/18
08:51
Recommendations
Intuit analyst commentary  »

Intuit price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 04

    Dec

TGT

Target

$77.13

-1.9 (-2.40%)

08:50
11/20/18
11/20
08:50
11/20/18
08:50
Hot Stocks
Breaking Hot Stocks news story on Target »

Target says no update on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 03

    Mar

SPB

Spectrum Brands

$48.20

-11.16 (-18.80%)

08:49
11/20/18
11/20
08:49
11/20/18
08:49
Downgrade
Spectrum Brands rating change  »

Spectrum Brands…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TGT

Target

$77.13

-1.9 (-2.40%)

08:46
11/20/18
11/20
08:46
11/20/18
08:46
Hot Stocks
Target CEO 'very excited' about 2019, 2020 given reception to store remodels »

Target CEO Brian Cornell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 03

    Mar

TGT

Target

$77.13

-1.9 (-2.40%)

08:46
11/20/18
11/20
08:46
11/20/18
08:46
Technical Analysis
Technical Take: Target drops sharply after earnings disappoint »

The shares were last down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 03

    Mar

PRSP

Perspecta

$20.46

-0.85 (-3.99%)

08:46
11/20/18
11/20
08:46
11/20/18
08:46
Hot Stocks
Perspecta awarded $89.5M task order by Centers for Medicare & Medicaid »

Perspecta announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ITRI

Itron

$52.64

-1.13 (-2.10%)

08:46
11/20/18
11/20
08:46
11/20/18
08:46
Hot Stocks
Itron signs contract with Conelectricas R.L. »

Itron has signed a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FMS

Fresenius Medical

$39.01

-1.14 (-2.84%)

08:45
11/20/18
11/20
08:45
11/20/18
08:45
Recommendations
Fresenius Medical analyst commentary  »

Fresenius Medical price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TGT

Target

$77.13

-1.9 (-2.40%)

08:45
11/20/18
11/20
08:45
11/20/18
08:45
Hot Stocks
Breaking Hot Stocks news story on Target »

Target says Q3 inventory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 03

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.